Market closedNon-fractional
ICU Medical/ICUI
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About ICU Medical
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Ticker
ICUI
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
San Clemente, United States
Employees
14,000
Website
www.icumed.com
ICU Medical Metrics
BasicAdvanced
$2.9B
Market cap
-
P/E ratio
-$2.46
EPS
0.72
Beta
-
Dividend rate
Price and volume
Market cap
$2.9B
Beta
0.72
Financial strength
Current ratio
2.608
Quick ratio
0.931
Long term debt to equity
78.232
Total debt to equity
81.634
Interest coverage (TTM)
0.32%
Management effectiveness
Return on assets (TTM)
0.48%
Return on equity (TTM)
-2.85%
Valuation
Price to revenue (TTM)
1.26
Price to book
1.41
Price to tangible book (TTM)
-12.73
Price to free cash flow (TTM)
37.86
Growth
Revenue change (TTM)
-2.10%
Earnings per share change (TTM)
27.88%
3-year revenue growth
21.44%
3-year earnings per share growth
-17.21%
What the Analysts think about ICU Medical
Analyst Ratings
Majority rating from 4 analysts.
ICU Medical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$567M
-3.61%
Net income
-$39M
130.41%
Profit margin
-6.95%
139.66%
ICU Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.88
$1.57
$1.57
$0.96
-
Expected
$1.60
$1.39
$1.19
$0.82
$1.00
Surprise
17.50%
13.36%
31.66%
17.07%
-
ICU Medical News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ICU Medical stock?
ICU Medical (ICUI) has a market cap of $2.9B as of July 04, 2024.
What is the P/E ratio for ICU Medical stock?
The price to earnings (P/E) ratio for ICU Medical (ICUI) stock is 0 as of July 04, 2024.
Does ICU Medical stock pay dividends?
No, ICU Medical (ICUI) stock does not pay dividends to its shareholders as of July 04, 2024.
When is the next ICU Medical dividend payment date?
ICU Medical (ICUI) stock does not pay dividends to its shareholders.
What is the beta indicator for ICU Medical?
ICU Medical (ICUI) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell ICU Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.